Literature DB >> 22788257

Economic evaluations of childhood influenza vaccination: a critical review.

Anthony T Newall1, Mark Jit, Philippe Beutels.   

Abstract

The potential benefits of influenza vaccination programmes targeted at children have gained increasing attention in recent years. We conducted a literature search of economic evaluations of influenza vaccination in those aged ≤18 years. The search revealed 20 relevant articles, which were reviewed. The studies differed widely in terms of the costs and benefits that were included. The conclusions were generally favourable for vaccination, but often applied a wider perspective (i.e. including productivity losses) than the reference case for economic evaluations used in many countries. Several evaluations estimated outcomes from a single-year epidemiological study, which may limit their validity given the year-to-year variation in influenza transmissibility, virulence, vaccine match and prior immunity. Only one study used a dynamic transmission model able to fully incorporate the indirect herd protection to the wider community. The use of dynamic models offers great scope to capture the population-wide implications of seasonal vaccination efforts, particularly those targeted at children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22788257     DOI: 10.2165/11599130-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  75 in total

1.  Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Authors:  Karl Claxton; Mark Sculpher; Chris McCabe; Andrew Briggs; Ron Akehurst; Martin Buxton; John Brazier; Tony O'Hagan
Journal:  Health Econ       Date:  2005-04       Impact factor: 3.046

2.  Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches.

Authors:  A T Newall; C Viboud; J G Wood
Journal:  Epidemiol Infect       Date:  2009-11-27       Impact factor: 2.451

3.  Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981.

Authors:  A S Monto; J S Koopman; I M Longini
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

4.  The Japanese experience with vaccinating schoolchildren against influenza.

Authors:  T A Reichert; N Sugaya; D S Fedson; W P Glezen; L Simonsen; M Tashiro
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

5.  Influenza-associated deaths among children in the United States, 2003-2004.

Authors:  Niranjan Bhat; Jennifer G Wright; Karen R Broder; Erin L Murray; Michael E Greenberg; Maleeka J Glover; Anna M Likos; Drew L Posey; Alexander Klimov; Stephen E Lindstrom; Amanda Balish; Marie-jo Medina; Teresa R Wallis; Jeannette Guarner; Christopher D Paddock; Wun-Ju Shieh; Sherif R Zaki; James J Sejvar; David K Shay; Scott A Harper; Nancy J Cox; Keiji Fukuda; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

6.  Live attenuated versus inactivated influenza vaccine in infants and young children.

Authors:  Robert B Belshe; Kathryn M Edwards; Timo Vesikari; Steven V Black; Robert E Walker; Micki Hultquist; George Kemble; Edward M Connor
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

7.  Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Authors:  Douglas M Fleming; Pietro Crovari; Ulrich Wahn; Timo Klemola; Yechiel Schlesinger; Alexangros Langussis; Knut Øymar; Maria Luz Garcia; Alain Krygier; Herculano Costa; Ulrich Heininger; Jean-Louis Pregaldien; Sheau-Mei Cheng; Jonathan Skinner; Ahmad Razmpour; Melanie Saville; William C Gruber; Bruce Forrest
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

8.  Cost-effectiveness of influenza vaccination of healthy children.

Authors:  Heini Salo; Terhi Kilpi; Harri Sintonen; Miika Linna; Ville Peltola; Terho Heikkinen
Journal:  Vaccine       Date:  2006-04-07       Impact factor: 3.641

9.  Influenza vaccination.

Authors:  M A Riddiough; J E Sisk; J C Bell
Journal:  JAMA       Date:  1983-06-17       Impact factor: 56.272

10.  The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children.

Authors:  Stephen B Lambert; Kelly M Allen; Robert C Carter; Terence M Nolan
Journal:  Respir Res       Date:  2008-01-24
View more
  9 in total

1.  Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Authors:  Luis Salleras; Encarna Navas; Nuria Torner; Andreu A Prat; Patricio Garrido; Núria Soldevila; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

Review 2.  Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.

Authors:  Mark Jit; Anthony T Newall; Philippe Beutels
Journal:  Hum Vaccin Immunother       Date:  2013-01-28       Impact factor: 3.452

3.  Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability.

Authors:  Anthony T Newall; Juan Pablo Dehollain; Prudence Creighton; Philippe Beutels; James G Wood
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

4.  Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges.

Authors:  Sevan Dirmesropian; James G Wood; C Raina MacIntyre; Philippe Beutels; Anthony T Newall
Journal:  Pharmacoeconomics       Date:  2016-08       Impact factor: 4.981

5.  Influenza vaccination in the COVID-19 era.

Authors:  Victor Grech; Michael Borg
Journal:  Early Hum Dev       Date:  2020-06-18       Impact factor: 2.079

6.  The impact of influenza infection on young children, their family and the health care system.

Authors:  Gabriela A Willis; David B Preen; Peter C Richmond; Peter Jacoby; Paul V Effler; David W Smith; Christine Robins; Meredith L Borland; Avram Levy; Anthony D Keil; Christopher C Blyth
Journal:  Influenza Other Respir Viruses       Date:  2018-09-11       Impact factor: 4.380

Review 7.  Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review.

Authors:  Tanja Fens; Pieter T de Boer; Eugène P van Puijenbroek; Maarten J Postma
Journal:  Vaccines (Basel)       Date:  2021-02-02

Review 8.  Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.

Authors:  Jennifer L Jones; Frances Tse; Matthew W Carroll; Jennifer C deBruyn; Shelly A McNeil; Anne Pham-Huy; Cynthia H Seow; Lisa L Barrett; Talat Bessissow; Nicholas Carman; Gil Y Melmed; Otto G Vanderkooi; John K Marshall; Eric I Benchimol
Journal:  J Can Assoc Gastroenterol       Date:  2021-07-29

Review 9.  WHO guide on the economic evaluation of influenza vaccination.

Authors:  Anthony T Newall; Nathorn Chaiyakunapruk; Philipp Lambach; Raymond C W Hutubessy
Journal:  Influenza Other Respir Viruses       Date:  2017-12-27       Impact factor: 4.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.